Gong Chen



  1. Fan W, Wang F, Lu Z, Pan Z, Li L, Gao Y, et al. Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial. Chin J Cancer. 2015;34:394-403 pubmed publisher
    ..However, preoperative CCRT with XELOX yielded a high pCR rate. Newer techniques are needed to improve the staging accuracy, and further investigation is warranted. Chi CTR-TRC-08000122. ..
  2. Peng J, Dong C, Wang C, Li W, Yu H, Zhang M, et al. Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study. Cancer Commun (Lond). 2018;38:22 pubmed publisher
    ..Trial registration This study was initiated on January 22, 2014 and has been retrospectively registered with the registration number ChiCTR1800015434. ..
  3. Xu R, Shen L, Li J, Xu J, Bi F, Ba Y, et al. Expert consensus on maintenance treatment for metastatic colorectal cancer in China. Chin J Cancer. 2016;35:13 pubmed publisher
  4. request reprint
    Chen G. [Interpretation of the updates of NCCN 2017 version 1.0 guideline for colorectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20:28-33 pubmed
    ..dMMR tumors contain thousands of mutations, which can encode mutant proteins with the potential to be recognized and targeted by the immune system. It has therefore been hypothesized that dMMR tumors may be sensitive to PD-1 inhibitors. ..
  5. request reprint
    Wang Y, Chen G. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20:630-634 pubmed
  6. Zhang R, Zhou Z, Lu S, Lu Z, Wan D, Pan Z, et al. Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients. Sci Rep. 2017;7:16043 pubmed publisher
    ..004) and pathology types (P?=?0.049) were significant prognostic factors for disease-free survival. Pim-3 is a potential predictive biomarker for the response of rectal cancer to chemoradiotherapy. ..
  7. request reprint
    Chen G, Wang Y. [Updates of 2017 ESMO guideline for rectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20:1236-1242 pubmed
    ..In summary, 2017 version of ESMO guideline for rectal cancer is a more personalized and clinically relevant guideline. ..